Online TCGA splice‐seq database (Cancer Splicing Visualized) illustrated that in lung cancer patients, most of FANCI alternative splicing events are exon skipping, for instance, the PSI (possible splicing index) of exon 34 skipping is almost 98.7% incidence (https://bioinformatics.mdanderson.org/TCGASpliceSeq/singlegene.jsp), indicating these splicing events may involve in the regulation of lung cancer development and process. This evidence concerns the gene FANCI and cancer.